Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
04-08-02 Drugs used in status epilepticus
| Diazepam |
|
Formulary
|
Injection (solution) 10mg/2mL |
 MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression |
|
| Diazepam rectal tubes |
|
Formulary
|
Rectal solution tube 5mg/2.5ml, 10mg/2.5ml Status epilepticus. |
|
MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression |
|
| Lorazepam |
|
Formulary
|
Injection 4mg/1mL Status epilepticus. |
|
MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression |
|
|
| Midazolam Epistatus® |
|
Formulary
|
Oromucosal solution pre-filled oral syringes (Buccolam®) 2.5mg/0.5ml, 5mg/1ml, 7.5mg/1.5ml, 10mg/2ml Buccal liquid (Epistatus ®) 10mg/1mL Status epilepticus. When an oral midazolam preparation is prescribed, a licensed product should be prescribed. Buccal midazolam is available as both a 5mg/ml and 10mg/ml solution. To avoid confusion prescribe midazolam buccal solution using the brand name and state the dose in milligrams (mg) and millilitres (ml). |
|
CEWT: Epilepsy-to-go MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression MHRA: Buccal midazolam (Buccolam▼): new authorised medicine for paediatric use |
|
UnlicensedLinks
- BNF: Medical emergencies in the community
- CEWT: Epilepsy-to-go
- Children's Epilepsy Workstream in Trent
- DVLA: Epilepsy and driving fact sheet
LSCMMG: ADHD combined adult and child shared care guideline- LSCMMG: Opioid reduction: best interests opioid reduction position statement
- LSCMMG: Opioid treatment: patient-prescriber opioid treatment agreement
- LSCMMG: Restless Legs Syndrome in Adults in Primary Care
- MHRA Drug alert for Epistatus® - August 2012
- MHRA: Antiepileptic drugs: updated advice on switching between different manufacturers’ products
- MHRA: Antiepileptics: risk of suicidal thoughts and behaviour
- MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression
- MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression
- MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression
- MHRA: Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression
- MHRA: Buccal midazolam (Buccolam▼): new authorised medicine for paediatric use